Short Interest in Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF) Decreases By 17.4%

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF) was the recipient of a significant decrease in short interest in November. As of November 15th, there was short interest totalling 5,959,200 shares, a decrease of 17.4% from the October 31st total of 7,214,300 shares. Based on an average daily trading volume, of 3,800 shares, the days-to-cover ratio is currently 1,568.2 days.

Ono Pharmaceutical Price Performance

Ono Pharmaceutical stock remained flat at $11.35 during mid-day trading on Friday. The firm’s fifty day moving average is $12.93 and its 200 day moving average is $13.70. Ono Pharmaceutical has a one year low of $10.26 and a one year high of $19.09.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.